CDx Diagnostics and ENT & Allergy Associates Urge Women to Schedule Annual Oral Cancer Screenings

One Woman's Story Reminds All Women of the Importance of Health Awareness

News provided by

Oct 10, 2013, 09:00 ET

NEW YORK, Oct. 10, 2013 /PRNewswire/ -- When Marjorie Doherty walked into her physician's office, she did not know that the visit would save her life. She had a spot in her mouth, similar to one that many people have in their mouth at one time or another. Having no traditional risk factors, as Doherty was not a smoker or an abuser of alcohol, there was no apparent cause for alarm. But when Dr. Gangadhar Sreepada performed a BrushTest on the spot, oral precancer was discovered.

Last month, the nation celebrated Women's Health and Fitness Day, when women across the nation were reminded of the importance of making smart, healthy choices. ENT and Allergy Associates and CDx Diagnostics urge all women to take control of their health with regular screenings and wellness exams. An annual oral cancer screening is critical, especially since the disease has been made virtually preventable with the BrushTest. Oral cancer, a disease that claims the lives of twice as many Americans as cervical cancer and is rising among women, starts as a tiny, harmless red or white spot in the mouth. If the spot is detected in its precancerous stage, it can be removed long before it develops into cancer.

"What most people do not know is that a large percentage of oral cancer victims are nonsmokers; the importance of brushing every spot in the mouth is illustrated by Marjorie's case," says Dr. Sreepada, otolaryngologist at ENT & Allergy Associates. "Making this discovery allowed Marjorie to get the care she needed before the still-harmless abnormality developed into cancer."

When patients play an active role in their care, research shows outcomes are better. Women should express their concerns and choose doctors who are advocating for their health with the best medicine available. If someone sees or feels a spot in their mouth, they should get it checked out by their doctor.

To date, over 20,000 precancers and early oral cancers have been detected using the BrushTest. 46% of them have been from women.

For more information about the OralCDx BrushTest, visit www.oralcdx.com.

About CDx Diagnostics
CDx Diagnostics (www.CDxDiagnostics.com), makers of the OralCDx BrushTest, is the leader in the detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. The CDx tests are primarily used to help prevent cancer before it can start by identifying still-harmless dysplasia (precancer) and are also used to identify early stage cancers when they can be most easily cured. Clinicians use CDx patented brush biopsy instruments to non-invasively collect a broad, full thickness tissue specimen of a suspect lesion. This unique tissue specimen is then subjected to specialized, computer-assisted laboratory analysis. These life saving tests are nationally available to gastroenterologists, otolaryngologists, oral surgeons, periodontists, and dentists.

About ENT and Allergy Associates
Each ENT and Allergy Associates (www.entandallergy.com) clinical location provides access to a full complement of services, including General Adult and Pediatric ENT, Voice and Swallowing, Facial Plastics and Reconstructive Surgery, Disorders of the Inner Ear and Dizziness, Asthma, Clinical Immunology, Diagnostic Audiology, Hearing Aid dispensing, Sleep and CT Services. ENTA has a clinical alliance with The Mount Sinai Hospital for the treatment of diseases of the head and neck and esophageal cancer and a partnership with the American Cancer Society to educate and treat patients with smoking disorders and cancer. The Practice has also expanded its clinical capabilities to include advanced immunodeficiency trials. To learn more about the benefits of ENT and Allergy Associates, or to conveniently find an ENT doctor or Allergy Doctor and then easily book an appointment at the nearest New York (NY) or New Jersey (NJ) location, please visit www.entandallergy.com.

Contact:
Sharon Golubchik
CDx Diagnostics
(609) 418-0058
[email protected]

SOURCE CDx Diagnostics